The Ki‐67 labeling indices varied from 70% to 90% in different regions of both the control and P4HA1‐KD tumors, apparently depending on the growth rates and cell cycle phases of the heterogeneous tumor cells (Miller et al., 2018). The gene discussed is MKI67; the disease is neoplasm.